• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脊髓性肌萎缩症SITTER患者的功能和结构分析。

Functional and structural analysis of SITTER patients with spinal muscular atrophy.

作者信息

Bieniaszewska Aleksandra, Sobieska Magdalena, Gajewska Ewa

机构信息

Department of Developmental Neurology, Poznan University of Medical Sciences, 60-355, Poznan, Poland.

Department of Rehabilitation and Physiotherapy, Poznan University of Medical Sciences, 61-545, Poznan, Poland.

出版信息

Sci Rep. 2025 Mar 28;15(1):10810. doi: 10.1038/s41598-025-95328-9.

DOI:10.1038/s41598-025-95328-9
PMID:40155702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11953399/
Abstract

In recent years, three disease-modifying therapies have been approved and fully reimbursed in Poland since September 2023. Those therapies have significantly improved the disease outcome but led to new uncertainties. Doubts mainly concern older patients who have already developed complications occurring because of a lack of previous access to therapy. Joint contractures or trunk deformation are the most noticeable changes that should be examined. This work examines functional and structural changes in SMA sitter patients between the ages of 5 and 20 years during the 12-month follow-up. Twenty-one SMA patients were divided depending on the drug program in which they participated. The study protocol included functional and structural assessments. Most of the subjects experienced an improvement in cervical rotation parameter and increased contracture of the hip and knee joints. There are differences between the patients' body sides. Neither the contractures nor their gradual decrease or increase occur symmetrically. We conclude that all patients under study improved their motor function after 12 months. In both groups, more significant improvement occurred in the assessment of the RULM scale than in the HFMSE scale. Improvement in function was not dependent on improvement in structural parameters.

摘要

近年来,自2023年9月起,三种疾病修正疗法在波兰已获批并全额报销。这些疗法显著改善了疾病预后,但也带来了新的不确定性。疑虑主要涉及那些因之前无法获得治疗而已经出现并发症的老年患者。关节挛缩或躯干变形是最明显的变化,需要进行检查。这项研究观察了年龄在5至20岁之间的脊髓性肌萎缩症(SMA)坐立患者在12个月随访期间的功能和结构变化。21名SMA患者根据他们所参与的药物方案进行分组。研究方案包括功能和结构评估。大多数受试者的颈椎旋转参数有所改善,髋部和膝关节挛缩增加。患者身体两侧存在差异。挛缩情况及其逐渐减轻或加重并非对称发生。我们得出结论,所有研究中的患者在12个月后运动功能均有所改善。在两组中,上肢功能评定量表(RULM)的评估改善比粗大运动功能测量扩展版(HFMSE)量表更为显著。功能的改善并不依赖于结构参数的改善。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dda/11953399/e2bea5a5c569/41598_2025_95328_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dda/11953399/f5d6782578dc/41598_2025_95328_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dda/11953399/b40e2e2034c7/41598_2025_95328_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dda/11953399/e2bea5a5c569/41598_2025_95328_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dda/11953399/f5d6782578dc/41598_2025_95328_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dda/11953399/b40e2e2034c7/41598_2025_95328_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5dda/11953399/e2bea5a5c569/41598_2025_95328_Fig3_HTML.jpg

相似文献

1
Functional and structural analysis of SITTER patients with spinal muscular atrophy.脊髓性肌萎缩症SITTER患者的功能和结构分析。
Sci Rep. 2025 Mar 28;15(1):10810. doi: 10.1038/s41598-025-95328-9.
2
Long-term impact of nusinersen on motor and electrophysiological outcomes in adolescent and adult spinal muscular atrophy: insights from a multicenter retrospective study.依地膦酸钠治疗骨转移的疗效及安全性:系统评价与 Meta 分析
J Neurol. 2024 Sep;271(9):6004-6014. doi: 10.1007/s00415-024-12567-y. Epub 2024 Jul 19.
3
Quantitative Evaluation of Lower Extremity Joint Contractures in Spinal Muscular Atrophy: Implications for Motor Function.脊髓性肌萎缩症下肢关节挛缩的定量评估:对运动功能的影响
Pediatr Phys Ther. 2018 Jul;30(3):209-215. doi: 10.1097/PEP.0000000000000515.
4
Motor function and compound muscle action potential amplitude in children with spinal muscular atrophy treated with nusinersen.接受诺西那生治疗的脊髓性肌萎缩症患儿的运动功能和复合肌肉动作电位幅度
Brain Dev. 2025 Feb;47(1):104316. doi: 10.1016/j.braindev.2024.104316. Epub 2025 Jan 8.
5
Examination of Upper Limb Function and the Relationship with Gross Motor Functional and Structural Parameters in Patients with Spinal Muscular Atrophy.脊髓性肌萎缩症患者上肢功能检查及其与粗大运动功能和结构参数的关系
Biomedicines. 2023 Mar 24;11(4):1005. doi: 10.3390/biomedicines11041005.
6
Safety and Treatment Effects of Nusinersen in Longstanding Adult 5q-SMA Type 3 - A Prospective Observational Study.5q 型脊髓性肌萎缩症成年患者使用 nusinersen 的安全性和治疗效果:一项前瞻性观察研究。
J Neuromuscul Dis. 2019;6(4):453-465. doi: 10.3233/JND-190416.
7
Risdiplam improves subjective swallowing quality in non-ambulatory adult patients with 5q-spinal muscular atrophy despite advanced motor impairment.尽管存在严重运动功能障碍,但利司扑兰可改善非卧床成年5q脊髓性肌萎缩症患者的主观吞咽质量。
J Neurol. 2024 May;271(5):2649-2657. doi: 10.1007/s00415-024-12203-9. Epub 2024 Feb 15.
8
Long-term nusinersen treatment across a wide spectrum of spinal muscular atrophy severity: a real-world experience.长期依库珠单抗治疗广泛范围脊髓性肌萎缩症严重度:真实世界经验。
Orphanet J Rare Dis. 2023 Aug 4;18(1):230. doi: 10.1186/s13023-023-02769-4.
9
Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study.在接受nusinersen 治疗的非瘫痪型 2 型和 3 型 SMA 患儿中上肢功能得到改善:前瞻性 3 年 SMArtCARE 登记研究。
Orphanet J Rare Dis. 2022 Oct 23;17(1):384. doi: 10.1186/s13023-022-02547-8.
10
Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3.2型和3型脊髓性肌萎缩未经治疗患者队列中修订版哈默史密斯量表的疾病轨迹
J Neuromuscul Dis. 2024;11(3):665-677. doi: 10.3233/JND-230211.

本文引用的文献

1
The Impact of Nusinersen and Risdiplam on Motor Function for Spinal Muscular Atrophy Type 2 and 3: A Meta-Analysis.《依地膦酸钠和利司扑兰对 2 型和 3 型脊髓性肌萎缩症运动功能影响的荟萃分析》。
J Coll Physicians Surg Pak. 2024 Aug;34(8):948-955. doi: 10.29271/jcpsp.2024.08.948.
2
Functional and Structural Changes in Patients with Spinal Muscular Atrophy Treated in Poland during 12-Month Follow-Up: A Prospective Cohort Study.波兰脊髓性肌萎缩症患者在12个月随访期间的功能和结构变化:一项前瞻性队列研究
J Clin Med. 2024 Jul 19;13(14):4232. doi: 10.3390/jcm13144232.
3
Long-term impact of nusinersen on motor and electrophysiological outcomes in adolescent and adult spinal muscular atrophy: insights from a multicenter retrospective study.
依地膦酸钠治疗骨转移的疗效及安全性:系统评价与 Meta 分析
J Neurol. 2024 Sep;271(9):6004-6014. doi: 10.1007/s00415-024-12567-y. Epub 2024 Jul 19.
4
Changes in abilities over the initial 12 months of nusinersen treatment for type II SMA.脊髓性肌萎缩症 II 型患者接受 nusinersen 治疗最初 12 个月的能力变化。
Neuromuscul Disord. 2024 Aug;41:42-50. doi: 10.1016/j.nmd.2024.05.003. Epub 2024 May 9.
5
Nusinersen therapy changed the natural course of spinal muscular atrophy type 1: What about spine and hip?诺西那生治疗改变了1型脊髓性肌萎缩症的自然病程:脊柱和髋关节情况如何?
J Child Orthop. 2024 Mar 8;18(3):322-330. doi: 10.1177/18632521241235028. eCollection 2024 Jun.
6
Beyond Contractures in Spinal Muscular Atrophy: Identifying Lower-Limb Joint Hypermobility.脊髓性肌萎缩症中的挛缩之外:识别下肢关节活动过度。
J Clin Med. 2024 Apr 30;13(9):2634. doi: 10.3390/jcm13092634.
7
Risdiplam therapy in adults with 5q-SMA: observational study on motor function and treatment satisfaction.利司扑兰治疗成人 5q 型脊肌萎缩症:运动功能和治疗满意度的观察性研究。
BMC Neurol. 2024 Feb 17;24(1):67. doi: 10.1186/s12883-024-03562-x.
8
Safety and Efficacy of Nusinersen and Risdiplam for Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.诺西那生钠和利司扑兰治疗脊髓性肌萎缩症的安全性和有效性:一项随机对照试验的系统评价和荟萃分析
Brain Sci. 2023 Oct 7;13(10):1419. doi: 10.3390/brainsci13101419.
9
Spinal Muscular Atrophy: An Evolving Scenario through New Perspectives in Diagnosis and Advances in Therapies.脊髓性肌萎缩症:诊断新视角和治疗新进展带来的演变。
Int J Mol Sci. 2023 Oct 3;24(19):14873. doi: 10.3390/ijms241914873.
10
Systematic Literature Review of the Natural History of Spinal Muscular Atrophy: Motor Function, Scoliosis, and Contractures.脊髓性肌萎缩症自然史的系统文献回顾:运动功能、脊柱侧凸和挛缩。
Neurology. 2023 Nov 21;101(21):e2103-e2113. doi: 10.1212/WNL.0000000000207878. Epub 2023 Oct 9.